Biologics are used to treat many different autoimmune diseases by targeting inflammatory cytokines (TNF-α and IL-6) and cytokine receptors, interrupting the inflammatory vicious cycle, and are recommended even in early RA with low-severity inflammatory arthritis [91,112]. This evidence concerns the gene IL6 and rheumatoid arthritis.